Skip to main content

beta This is a new site, your feedback will help us to improve it.

Lutathera for neuroendocrine tumours

Published on 30 September 2021

Lutathera therapy treatment for neuroendocrine tumours (NETs) is provided at the Beatson West of Scotland Cancer Centre in Glasgow.

What is the Lutathera Therapy Service?

The service provides in-patient and follow-up treatment to people with small bowel NETs that are somatostatin receptor (SSR) positive. Lutathera therapy slows down the growth of tumours, or prevents them from growing altogether.

After each treatment, a post-therapy nuclear medicine scan assesses distribution of the Lutathera. Follow-up care will continue to be provided jointly by the patient’s local team and the national service.

Lead clinician

Professor Nick Reed, Consultant Clinical Oncologist, NHS Greater Glasgow & Clyde

Address

Beatson West of Scotland Cancer Centre
1053 Great Western Road
Glasgow
G12 0YN

NSD contact

Programme Manager, Joanne Milne-Toner – joanne.milne-toner@nhs.scot – 0131 2756558

Please note that NSD does not directly provide medical services and we won't be able to answer queries about your own care or appointments. If you would like to discuss any aspects of your care, please contact your primary healthcare provider. This might be your GP, Consultant, Nurse or other healthcare professional. They will be best placed to give you the right advice.